Vote Scores
Filings read through

Actinium Pharmaceuticals, Inc.: how funds voted at the meeting of 26 Nov 2025

Ticker
ATNM
Meeting
Season
year to 30 June 2026
Filers reporting
60
Ballot items
4

60 filers on Form N-PX reported votes at the Actinium Pharmaceuticals, Inc. meeting of 26 Nov 2025. The records fall into 4 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.

If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.

The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .

The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.

The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.

The page gives records. It gives no investment advice and no advice on how to vote.

Season on this page: year to 30 June 2026. Filings read through . How the figures are made

The ballot

ForAgainstAbstain, withhold or otherAmber tick: the part cast against management

  1. Item 1: Director elections

    2 nominees. 92.3% of the reported votes are for. 2 filers withheld from or voted against at least one nominee.

    26 vote records from 9 filers. 0 of the 9 filers that marked the item voted against management.

    • Positions of 5 fund families
    • For 4
    • Split or no vote 1
  2. Item 2: Advisory vote on executive pay (say-on-pay)

    72 vote records from 60 filers. 3 of the 55 filers that marked the item voted against management. 5 filers gave no management mark.

    • Positions of 11 fund families
    • For 9
    • Against 2
    • Against management 2
  3. Item 3: Frequency of the say-on-pay vote

    One year: 46 filers. Three years: 4 filers. 1-year: 1 filer. For: 1 filer. Not applicable: 1 filer. Take no action: 1 filer.

    69 vote records from 57 filers. 47 of the 51 filers that marked the item voted against management. 6 filers gave no management mark.

    • Positions of 11 fund families
    • Split or no vote 11
    • Against management 9
  4. Item 4: Audit-related items (auditor ratification)

    13 vote records from 9 filers. 0 of the 9 filers that marked the item voted against management.

    • Positions of 5 fund families
    • For 5

Positions of the fund families

A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.

KeyForAgainstAbstain or withholdSplit or no voteAgainst management

Fund families at Actinium Pharmaceuticals, Inc., meeting of 26 Nov 2025Families in name order. "Abstain" includes withhold. "Split" includes no vote. "No report" means that no filer of the family listed the item.
Fund family2. Say-on-pay3. Pay-vote frequency4. Auditor
BlackRock and iSharesForSplit, against managementFor
BNY MellonForSplit, against managementNo report
DimensionalAgainst, against managementSplitNo report
EquitableForSplit, against managementFor
Federated HermesForSplit, against managementNo report
FidelityForSplit, against managementFor
Goldman SachsForSplit, against managementNo report
Jackson National fundsAgainst, against managementSplitFor
Northern Trust and FlexSharesForSplit, against managementNo report
State Street and SPDRForSplit, against managementNo report
VanguardForSplit, against managementFor

Questions

How many filers reported votes at the Actinium Pharmaceuticals, Inc. meeting?
60 Form N-PX filers reported votes at the meeting of 26 Nov 2025. On say-on-pay, 3 of 55 filers that marked the item voted against management (5.5%).
Is this the result of the meeting?
No. The page counts the filers that report on Form N-PX, and the shares they reported. Actinium Pharmaceuticals, Inc. reports the result of a vote on Form 8-K.
Why does the page show counts only for director elections?
A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.

Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Actinium Pharmaceuticals, Inc. with a meeting date within three days of 26 Nov 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .